A new method of intra-arterial regional chemotherapy with more selective drug delivery for locally advanced pancreatic cancer

Hepato-Gastroenterology

Volumn 43, Issue 8, 1996, Pages 338-345

  Ohigashi, Hiroaki ^a   Ishikawa, Osamu ^a   Imaoka, Shingi ^a   Sasaki, Yo ^a   Kabuto, Toshiyuki ^a   Kameyama, Masao ^a   Furukawa, Hiroshi ^a   Hiratuka, Masahiro ^a   Nakamori, Syoji ^a   Nakano, Hirohumi ^a   Yasuda, Takusi ^a   Iwanaga, Takeshi ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Angiotensin II; Liver metastasis; Methotrexate 5 fluorouracil; Pancreatic cancer

Indexed keywords

ANGIOTENSIN; ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINATE CALCIUM; METHOTREXATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LAPAROTOMY; LIVER METASTASIS; MALE; ORAL DRUG ADMINISTRATION; PANCREAS CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; SPLEEN ARTERY; TUMOR BLOOD FLOW; TUMOR REGRESSION;

AGED; ANGIOTENSIN II; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, DUCTAL, BREAST; CATHETERIZATION; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, INTRALESIONAL; MALE; METHOTREXATE; MIDDLE AGED; PANCREATIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 9244243089     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Connelly M, Dawson P, Michelassi F, Moossa A, Lowenstein F. Survival in 1001 patients with carcinoma of the pancreas. Ann. Surg 1987; 206: 366-373.
2. Fortner JG. Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Ann Surg 1984;199:418-425.
3. Sindelar WF. Clinical experience with regional pancreatectomy for adenocarcinonia of the pancreas. Arch Surg 1989;124:127-132.
4. Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J. Natl. Cancer Inst. 1988;80:751-755.
5. Gunderson LL, Martin JK, Kvols LK, et al. Intraoperative and external beam irradiation ± 5-FU for locally advanced pancreatic cancer. Int. J. radiation Oncology Biol. Phys. 1987;13:319-329.
6. Komaki R, Wadler S, Peters T, et al. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801). Cancer 1992;69(11):2807-12.
7. Joyce F, Burcharth F, Holm HH, Stroyer I. Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma. Int J Radiat Oncol Biol Phys 1990;19(4):1049-1052.
8. McCracken JD, Olson M, Cruz AB, Leichman L, Oishi N. Radiation therapy combined with intra-arterial 5-FU chemotherapy for treatment of localized adenocarcinoma of the pancreas. Cancer Treatment Reports 1982;66:549-551.
9. Mohiuddin M, Rosato F, Barbot D, Schuricht A, Biermann W, Cantor R. Long-term results of combined modality treatment with I-I25 implantation for carcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1992;23(2):305-11.
10. Raju PI, Maruyama Y, MacDonald J, DeSimone P. Treatment of unresectable pancreatic carcinoma using irradiation with concurrent intravenous 5-FU infusion therapy. Cancer Investigation 1988;6:263-266.
11. Roldan GE, Gunderson LL, Nagorney DM, et al. External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 1988;61:1110-1116.
12. Seydel H, Stablein D, Leichman L, Kinzie J, Thomas P. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience. Cancer 1990;65(7):1478-1482.
13. Wiley AL Jr, Wirtanen GW, Mehta MP, Ramirez G, Shahabi S. Treatment of probable subclinical liver metastases and gross pancreatic carcinoma with hepatic artery 5-Fluorouracil infusion and radiation therapy. Acta Oncologica 1988;27:377-381.
14. Theodors A, Bukowski R, Hewlett J, et al. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Am J Clin Oncol 1982;5:555-558.
15. Hafström L, Ihse I, Jonsson P, Lunderquist A, Stridbeck H. Intraarterial 5-FU infusion with or without oral testolactone treatment in irresectable pancreatic cancer. Acta Chir Scand 1980;146:445-448.
16. Miura K, Wada T. Clinical effects of hyperthermia in advanced malignancy; preliminary clinical results of combined 2450 Megahertz microwave therapy and intraarterial chemotherapy with a special reference to the patients with cancer of head of pancreas. Gastroenterol Surg 1981;4:181-192.
17. Smith L, Gazel J. Intra-arterial chemotherapy for patients with inoperable carcinoma of the pancreas. Ann R Coll Surg Engl 1980;62:208-212.
18. Cullian SA, Moertel CG, Fleming TR, et al. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. JAMA 1985;253:2061-2067.
19. Scheithauer W, Pfeffel F, Kornek G, Marczell A, Wiltschke C, Funovics J. A Phase II trial of 5-Fluorouracil, Leucovorin, and recombinant Alpha-2b-interferon in advanced adenocarcinoma of the pancreas. Cancer 1992;70:1864-1866.
20. Linstadt D, Quivery J, Castro JR, Andejeski Y, Phillips TL, Gribble M. Comparison of helium-ion radiation therapy and split-course megavoltage irradiation for unresectable adenocarcinoma of the pancreas. Radiology 1988;168:261-264.
21. Cohen L, Woodruff KH, Hendrickson FR, et al. Response of pancreatic cancer to local irradiation with high-energy neutrons. Cancer 1985;56:1235-1241.
22. Peretz T, Nori D, Hilaris B, et al. Treatment of primary unresectable carcinoma of the pancreas with I-125 implantation. Int. J. Radiation Oncology Biol. Phys. 1989;17:931-935.
23. Whittington R, Dubelbower RR, Mohiuddin M, Rusato F. Radiation of unresectable pancreatic carcinoma: A six year experience with 104 patients. Int Int J Radiatiun Oncology Biol Phys 1981;7:1639-1644.
24. Ishida H, Makino T, Kobayashi M, Tsuneoka K. Laparoscopic: measurement of pancreatic blood flow. Endoscopy 1983;15:107-110.
25. Sasaki Y, Imaoka S, Hasegawa Y, et al. Changes in distribution of blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer. Cancer 1985; 55:311-316.
26. Noguchi S, Miyauchi K, Nishizawa Y, et al. Augmentation of anticancer effect with angiotensin II in intraarterial infusion chemotherapy for breast carcinoma. Cancer 1988;62(3):467-73.
27. Zubord C, Schneiderman M, Frei E, et al. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogenmustard and triethylene thiophosphoramide. J Chron Dis 1960;11:7-33.
28. Ohigasi H, Ishikawa O, Nakamori S, Sasaki Y, Imaoka S, Iwanaga T. Pharmacological effect of angiotensin II and prostaglandin El on the hemodynamic change in patients with unresectable pancreas cancer treated with intraarterial infusion chemotherapy. Jpn J Gastroenterol Surg 1986;19:1629-1638. (Abstract in English)
29. Mattson J, Appelgren L, Karlsson L, Peterson M. Influence of vasoactive drugs and ischamia on intratumor blood flow distribution. Europ. J. Cancer 1978;14:761-764.
30. Yaegushi H, Takahashi T. Encasement and other deformations of tumor-embedded host arteries due to loss of medial smooth muscles. Morphometric and three-dimensional reconstruction studies on some human carcinoma. Cancer 1990;65:1097-1103.
31. Djerassi I, Kim SJ, Nayak N, Ohanissian H, Adler S. High-close Methotrexate with citrovorum factor rescue: A new approach to cancer chemotherapy. New York: Raven Press, 1977: 201-225.
32. Yasuda T, Ishikawa O, Ohigashi H. Preventive effects of intra-arterial infusion chemotherapy for liver metastasis in non-resectable pancreatic cancer. Jpn. J. Cancer Chemother 1989;16:2863-2866. (Abstract in English)
33. Bertino JR, Sawicki WL, Lindquist CA, Gupta VS. Schedule-dependent antitumor effect of methotrexate and 5-Fluorouracil. Cancer Res 1977; 37:327-328.
34. Bukowski RM, Schacter LP, Groppe CW, Hewlett JS, Weick JK, Livingston RB. Phase II trial of 5-Fluorouracil, Adriamycin, Mitomycin C, and Streptozotocin (FAM-S) in pancrcatic carcinoma. Cancer 1982;50:197-200.
35. Smith FP, Hoth DF, Levin B, et al. 5-Fluorouracil, Adriamycin, and Mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas. Cancer 1980;46:2014-2018.
36. Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-Fluorouracil), and high close radiation + 5-Fluorouracil. Cancer 1981;48:1705-1710.
37. Ishikawa O, Ohigashi H, Imaoka S, et al. Preoperative indication for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surgery 1992;215:231-236.